<DOC>
	<DOC>NCT02665260</DOC>
	<brief_summary>The purpose of this study is to determine if cantharidin is a safe and effective treatment for molluscum contagiosum in kids</brief_summary>
	<brief_title>Safety and Efficacy Study of Topical Cantharidin for the Treatment of Molluscum Contagiosum</brief_title>
	<detailed_description>This was a double-blind, placebo-controlled trial. Participants were recruited from the Pediatric Dermatology clinic at Montefiore Medical Center. One hundred eligible participants were randomly assigned to receive cantharidin 0.7% topical, cantharidin 0.7% topical with occlusion, placebo, or placebo with occlusion. Treatments were applied at weeks 0 and 3 (blinded phase). At week 6, all participants were treated with open-label, topical cantharidin 0.7% without occlusion every 3 weeks until all lesions resolved (open-label phase).</detailed_description>
	<mesh_term>Molluscum Contagiosum</mesh_term>
	<mesh_term>Cantharidin</mesh_term>
	<criteria>217years Healthy &lt;50 molluscum contagiosum lesions Immunosuppressed Oral corticosteroids Sexually active/pregnant</criteria>
	<gender>All</gender>
	<minimum_age>2 Years</minimum_age>
	<maximum_age>17 Years</maximum_age>
	<verification_date>January 2016</verification_date>
</DOC>